Published in Neuropsychiatr Dis Treat on August 02, 2017
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care (1992) 144.02
The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med (2001) 76.04
A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med (2006) 21.56
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology (1996) 8.82
Validation of the Brief Pain Inventory for chronic nonmalignant pain. J Pain (2004) 5.12
Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry (2008) 4.98
Systematic review of misdiagnosis of conversion symptoms and "hysteria". BMJ (2005) 4.25
Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature. J Neurol Neurosurg Psychiatry (2000) 2.90
The guideline "consultation psychiatry" of the Netherlands Psychiatric Association. J Psychosom Res (2009) 2.78
Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci (2003) 2.03
Psychopathology and psychogenic movement disorders. Mov Disord (2011) 2.02
Initial letter and semantic category fluency in Alzheimer's disease, Huntington's disease, and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry (1994) 1.85
Language function and dysfunction in corticobasal degeneration. Neurology (2003) 1.78
Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain (2008) 1.72
Progressive supranuclear palsy: where are we now? Lancet Neurol (2002) 1.65
Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry (2000) 1.53
[Conversion disorder: from DSM IV to DSM 5 or from a psychiatric to a neurological diagnosis]. Tijdschr Psychiatr (2015) 1.42
Cognitive dysfunction in depression: neurocircuitry and new therapeutic strategies. Neurobiol Learn Mem (2011) 1.37
Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med (2013) 1.31
Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain (2010) 1.30
Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy. Neurology (1991) 1.28
Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J Neurol Neurosurg Psychiatry (1994) 1.21
Effect of psychiatric consultation models in primary care. A systematic review and meta-analysis of randomized clinical trials. J Psychosom Res (2010) 1.19
The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain (1995) 1.13
Functional (conversion) neurological symptoms: research since the millennium. J Neurol Neurosurg Psychiatry (2012) 1.11
The validity of hysterical signs and symptoms. J Nerv Ment Dis (1986) 1.10
Who is referred to neurology clinics?--the diagnoses made in 3781 new patients. Clin Neurol Neurosurg (2010) 1.08
Loss of insight in frontotemporal dementia, corticobasal degeneration and progressive supranuclear palsy. Brain (2007) 1.08
La belle indifférence in conversion symptoms and hysteria: systematic review. Br J Psychiatry (2006) 1.08
Evidence of an early information processing speed deficit in unipolar major depression. Psychol Med (2002) 1.03
Conversion disorder: a problematic diagnosis. J Neurol Neurosurg Psychiatry (2010) 1.03
Frontal lobe function in progressive supranuclear palsy. Arch Neurol (1990) 1.02
SUPRANUCLEAR OPHTHALMOPLEGIA, PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA. A CLINICAL REPORT ON EIGHT CASES OF "HETEROGENOUS SYSTEM DEGENERATION". Trans Am Neurol Assoc (1963) 1.00
Cognition in corticobasal syndrome and progressive supranuclear palsy: a review. Mov Disord (2014) 1.00
Cognitive bedside assessment in atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry (2005) 0.99
Neurologists' understanding and management of conversion disorder. J Neurol Neurosurg Psychiatry (2011) 0.96
Similarities between familial and sporadic autopsy-proven progressive supranuclear palsy. Neurology (2013) 0.94
Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy. Arch Clin Neuropsychol (2012) 0.92
The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders. J Neurol Neurosurg Psychiatry (2013) 0.92
Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology. Eur J Neurol (2013) 0.92
Health-related quality of life in patients with progressive supranuclear palsy. Mov Disord (2003) 0.91
Functional symptoms in neurology: mimics and chameleons. Pract Neurol (2013) 0.90
Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing. Neurocase (2005) 0.87
Language disturbances in corticobasal degeneration. Neurology (2000) 0.85
Epilepsy--la belle indifférence? Lancet (1987) 0.85
Which neurological diseases are most likely to be associated with "symptoms unexplained by organic disease". J Neurol (2011) 0.84
[Does routine outcome monitoring have a promising future? An investigation into the use of shared decision-making combined with ROM for patients with a combination of physical and psychiatric symptoms]. Tijdschr Psychiatr (2014) 0.84
Differentiation of parkinsonian syndromes according to differences in executive functions. J Neural Transm (Vienna) (2003) 0.84
Neuropsychological performance, disease severity, and depression in progressive supranuclear palsy. J Neurol (1996) 0.83
Fifty years of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry (2013) 0.81
The value of 'positive' clinical signs for weakness, sensory and gait disorders in conversion disorder: a systematic and narrative review. J Neurol Neurosurg Psychiatry (2013) 0.80
Efficacy of brief interdisciplinary psychotherapeutic intervention for motor conversion disorder and nonepileptic attacks. Gen Hosp Psychiatry (2015) 0.78
Psychophysiological correlates of la belle indifférence. Arch Gen Psychiatry (1969) 0.76
[Somatoform disorders in neurology visits: history and circumstances: retrospective study of 124 cases]. Rev Neurol (Paris) (2012) 0.76
[The practice guideline 'Consultation psychiatry' of the Dutch Psychiatric Association for psychiatric consultations in primary care and the hospital]. Ned Tijdschr Geneeskd (2008) 0.76
Diagnosis and management of functional neurological symptoms: The Dutch experience. Clin Neurol Neurosurg (2014) 0.76
Functional neurological disorders: the neurological assessment as treatment. Neurophysiol Clin (2014) 0.76
Can we increase adherence to treatment recommendations of the consultation psychiatrist working in a general hospital? A systematic review. J Psychosom Res (2010) 0.76
La belle indifference: medical myth or useful marker of psychiatric disease. Med Health R I (2001) 0.76
[The conversion disorder in the DSM-5: what's in a name?]. Tijdschr Psychiatr (2015) 0.75